<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2009 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER IX - GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME</span><br/>
<span style="font-size:10pt">Part A - Genetic Diseases</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_-ch6A-scIX-Part_A currentthrough:20100201 documentPDFPage:811 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A -->
<!-- itemsortkey:420ABLT -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases -->
<!-- field-start:structuralhead -->
<h3 class="part-head"><cap-smallcap>Part A&mdash;Genetic Diseases</cap-smallcap></h3>
<!-- field-end:structuralhead -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1976&mdash;Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407, substituted &ldquo;Genetic Diseases&rdquo; for &ldquo;Sickle Cell Anemia Programs&rdquo; in part A heading.</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b  usckey:420000000030000000000000b00000000 currentthrough:20100201 documentPDFPage:811 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b -->
<!-- itemsortkey:420ABLU -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b -->
<!-- field-start:repealedhead -->
<h3 class="section-head">&sect;300b. Repealed. Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(1), Aug. 13, 1981, 95 Stat. 827</h3>
<!-- field-end:repealedhead -->
<!-- field-start:repealsummary -->
<p class="note-body">Section, act July 1, 1944, ch. 373, title XI, &sect;1101, as added Apr. 22, 1976, Pub. L. 94&ndash;278, title IV, &sect;403(a), 90 Stat. 407; amended Nov. 10, 1978, Pub. L. 95&ndash;626, title II, &sect;205(b), (d)(2), (e), 92 Stat. 3583, 3584; Pub. L. 96&ndash;88, title V, &sect;509(b), Oct. 17, 1979, 93 Stat. 695; Aug. 13, 1981, Pub. L. 97&ndash;35, title XXI, &sect;2193(a)(1)(B), 95 Stat. 826; Jan. 4, 1983, Pub. L. 97&ndash;414, &sect;8(<em>o</em>), 96 Stat. 2061, related to testing, counseling, information and education programs.</p>
<p class="note-body">A prior section 300b, act July 1, 1944, ch. 373, title XI, &sect;1101, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 137; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(2), 86 Stat. 652, authorized Secretary to make grants and enter contracts with public and nonprofit private entities with respect to establishment of voluntary sickle cell anemia screening and counseling programs and to develop and disseminate informational and educational materials relating to sickle cell anemia, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:repealsummary -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-repeal-amendment-note -->
<h4 class="note-head">Effective Date of 1981 Amendment and Repeal, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to the amendment and repeal of this section by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-repeal-amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-1  usckey:420000000030000000000000b00010000 currentthrough:20100201 documentPDFPage:811 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-1 -->
<!-- itemsortkey:420ABLV -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-1 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;1. Research project grants and contracts</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">In carrying out section 241 of this title, the Secretary may make grants to public and nonprofit private entities, and may enter into contracts with public and private entities and individuals, for projects for (1) basic or applied research leading to the understanding, diagnosis, treatment, and control of genetic diseases, (2) planning, establishing, demonstrating, and developing special programs for the training of genetic counselors, social and behavioral scientists, and other health professionals, (3) the development of programs to educate practicing physicians, other health professionals, and the public regarding the nature of genetic processes, the inheritance patterns of genetic diseases, and the means, methods, and facilities available to diagnose, control, counsel, and treat genetic diseases, and (4) the development of counseling and testing programs and other programs for the diagnosis, control, and treatment of genetic diseases. In making grants and entering into contracts for projects described in clause (1) of the preceding sentence, the Secretary shall give priority to applications for such grants or contracts which are submitted for research on sickle cell anemia and for research on Cooley's anemia.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1102, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 408.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;1, act July 1, 1944, ch. 373, title XI, &sect;1102, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 138, authorized Secretary to make grants and enter contracts with public and private entities and individuals for projects concerned with research, research training in diagnosis, treatment and control of sickle cell anemia, informational and educational programs with respect to sickle cell anemia and development of counseling and testing programs, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section 403(c) of Pub. L. 94&ndash;278 provided that: &ldquo;The amendments made by subsections (a) and (b) [see section 401 of Pub. L. 94&ndash;278, set out as a Short Title of 1976 Amendment note under section 201 of this title] shall take effect July 1, 1976.&rdquo;</p>
<!-- field-end:effectivedate-note -->
<!-- field-start:shorttitle-amendment-note -->
<h4 class="note-head">Short Title of 1976 Amendment</h4>
<p class="note-body">For short title of title IV of Pub. L. 94&ndash;278, which enacted this part, omitted former part B of this subchapter, redesignated former parts C and D of this subchapter as parts B and C of this subchapter, respectively, as the &ldquo;National Sickle Cell Anemia, Cooley's Anemia, Tay-Sachs, and Genetic Diseases Act&rdquo;, see section 401 of Pub. L. 94&ndash;278, set out as a note under section 201 of this title.</p>
<!-- field-end:shorttitle-amendment-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Demonstration Program for the Development and Establishment of Systemic Mechanisms for the Prevention and Treatment of Sickle Cell Disease</h4>
<p class="note-body">Pub. L. 108&ndash;357, title VII, &sect;712(c), Oct. 22, 2004, 118 Stat. 1559, provided that:</p>
<p class="note-body">&ldquo;(1) <cap-smallcap>Authority to conduct demonstration program.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>In general</cap-smallcap>.&mdash;The Administrator, through the Bureau of Primary Health Care and the Maternal and Child Health Bureau, shall conduct a demonstration program by making grants to up to 40 eligible entities for each fiscal year in which the program is conducted under this section [probably means this subsection] for the purpose of developing and establishing systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease, including through&mdash;</p>
<p class="note-body-2em">&ldquo;(i) the coordination of service delivery for individuals with Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(ii) genetic counseling and testing;</p>
<p class="note-body-2em">&ldquo;(iii) bundling of technical services related to the prevention and treatment of Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(iv) training of health professionals; and</p>
<p class="note-body-2em">&ldquo;(v) identifying and establishing other efforts related to the expansion and coordination of education, treatment, and continuity of care programs for individuals with Sickle Cell Disease.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Grant award requirements.&mdash;</cap-smallcap></p>
<p class="note-body-2em">&ldquo;(i) <cap-smallcap>Geographic diversity</cap-smallcap>.&mdash;The Administrator shall, to the extent practicable, award grants under <!-- PDFPage:812 -->this section [probably means this subsection] to eligible entities located in different regions of the United States.</p>
<p class="note-body-2em">&ldquo;(ii) <cap-smallcap>Priority</cap-smallcap>.&mdash;In awarding grants under this subsection, the Administrator shall give priority to awarding grants to eligible entities that are&mdash;</p>
<p class="note-body-3em">&ldquo;(I) Federally-qualified health centers that have a partnership or other arrangement with a comprehensive Sickle Cell Disease treatment center that does not receive funds from the National Institutes of Health; or</p>
<p class="note-body-3em">&ldquo;(II) Federally-qualified health centers that intend to develop a partnership or other arrangement with a comprehensive Sickle Cell Disease treatment center that does not receive funds from the National Institutes of Health.</p>
<p class="note-body">&ldquo;(2) <cap-smallcap>Additional requirements</cap-smallcap>.&mdash;An eligible entity awarded a grant under this subsection shall use funds made available under the grant to carry out, in addition to the activities described in paragraph (1)(A), the following activities:</p>
<p class="note-body-1em">&ldquo;(A) To facilitate and coordinate the delivery of education, treatment, and continuity of care for individuals with Sickle Cell Disease under&mdash;</p>
<p class="note-body-2em">&ldquo;(i) the entity's collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity that works with individuals who have Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(ii) the Sickle Cell Disease newborn screening program for the State in which the entity is located; and</p>
<p class="note-body-2em">&ldquo;(iii) the maternal and child health program under title V of the Social Security Act (42 U.S.C. 701 et seq.) for the State in which the entity is located.</p>
<p class="note-body-1em">&ldquo;(B) To train nursing and other health staff who provide care for individuals with Sickle Cell Disease.</p>
<p class="note-body-1em">&ldquo;(C) To enter into a partnership with adult or pediatric hematologists in the region and other regional experts in Sickle Cell Disease at tertiary and academic health centers and State and county health offices.</p>
<p class="note-body-1em">&ldquo;(D) To identify and secure resources for ensuring reimbursement under the medicaid program, State children's health insurance program, and other health programs for the prevention and treatment of Sickle Cell Disease.</p>
<p class="note-body">&ldquo;(3) <cap-smallcap>National coordinating center.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>Establishment</cap-smallcap>.&mdash;The Administrator shall enter into a contract with an entity to serve as the National Coordinating Center for the demonstration program conducted under this subsection.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Activities described</cap-smallcap>.&mdash;The National Coordinating Center shall&mdash;</p>
<p class="note-body-2em">&ldquo;(i) collect, coordinate, monitor, and distribute data, best practices, and findings regarding the activities funded under grants made to eligible entities under the demonstration program;</p>
<p class="note-body-2em">&ldquo;(ii) develop a model protocol for eligible entities with respect to the prevention and treatment of Sickle Cell Disease;</p>
<p class="note-body-2em">&ldquo;(iii) develop educational materials regarding the prevention and treatment of Sickle Cell Disease; and</p>
<p class="note-body-2em">&ldquo;(iv) prepare and submit to Congress a final report that includes recommendations regarding the effectiveness of the demonstration program conducted under this subsection and such direct outcome measures as&mdash;</p>
<p class="note-body-3em">&ldquo;(I) the number and type of health care resources utilized (such as emergency room visits, hospital visits, length of stay, and physician visits for individuals with Sickle Cell Disease); and</p>
<p class="note-body-3em">&ldquo;(II) the number of individuals that were tested and subsequently received genetic counseling for the sickle cell trait.</p>
<p class="note-body">&ldquo;(4) <cap-smallcap>Application</cap-smallcap>.&mdash;An eligible entity desiring a grant under this subsection shall submit an application to the Administrator at such time, in such manner, and containing such information as the Administrator may require.</p>
<p class="note-body">&ldquo;(5) <cap-smallcap>Definitions</cap-smallcap>.&mdash;In this subsection:</p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>Administrator</cap-smallcap>.&mdash;The term &lsquo;Administrator&rsquo; means the Administrator of the Health Resources and Services Administration.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Eligible entity</cap-smallcap>.&mdash;The term &lsquo;eligible entity&rsquo; means a Federally-qualified health center, a nonprofit hospital or clinic, or a university health center that provides primary health care, that&mdash;</p>
<p class="note-body-2em">&ldquo;(i) has a collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity with experience in working with individuals who have Sickle Cell Disease; and</p>
<p class="note-body-2em">&ldquo;(ii) demonstrates to the Administrator that either the Federally-qualified health center, the nonprofit hospital or clinic, the university health center, the organization or entity described in clause (i), or the experts described in paragraph (2)(C), has at least 5 years of experience in working with individuals who have Sickle Cell Disease.</p>
<p class="note-body-1em">&ldquo;(C) <cap-smallcap>Federally-qualified health center</cap-smallcap>.&mdash;The term &lsquo;Federally-qualified health center&rsquo; has the meaning given that term in section 1905(<em>l</em>)(2)(B) of the Social Security Act (42 U.S.C. 1396d(<em>l</em>)(2)(B)).</p>
<p class="note-body">&ldquo;(6) <cap-smallcap>Authorization of appropriations</cap-smallcap>.&mdash;There is authorized to be appropriated to carry out this subsection, $10,000,000 for each of fiscal years 2005 through 2009.&rdquo;</p>
<h4 class="note-head">Congressional Declaration of Purpose</h4>
<p class="note-body">Section 402 of Pub. L. 94&ndash;278, as amended by Pub. L. 95&ndash;626, title II, &sect;205(a), Nov. 10, 1978, 92 Stat. 3583, provided that: &ldquo;In order to preserve and protect the health and welfare of all citizens, it is the purpose of this title [see section 401 of Pub. L. 94&ndash;278, set out as a Short Title of 1976 Amendment note under section 201 of this title] to establish a national program to provide for basic and applied research, research training, testing, counseling, and information and education programs with respect to genetic diseases, and genetic conditions, such as Sickle Cell anemia, Cooley's Anemia, Tay&ndash;Sachs disease, cystic fibrosis, dysautonomia, hemophilia, retinitis pigmentosa, Huntington's chorea, muscular dystrophy, and genetic conditions leading to mental retardation or genetically caused mental disorders.&rdquo;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-2  usckey:420000000030000000000000b00020000 currentthrough:20100201 documentPDFPage:812 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-2 -->
<!-- itemsortkey:420ABLW -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-2 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;2. Voluntary participation by individuals</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">The participation by any individual in any program or portion thereof under this part shall be wholly voluntary and shall not be a prerequisite to eligibility for or receipt of any other service or assistance from, or to participation in, any other program.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1103, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 408.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;2, act July 1, 1944, ch. 373, title XI, &sect;1103, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 138; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(3), 86 Stat. 652, was identical to this section, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-3  usckey:420000000030000000000000b00030000 currentthrough:20100201 documentPDFPage:812 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-3 -->
<!-- itemsortkey:420ABLX -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-3 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;3. Application; special consideration to prior sickle cell anemia grant recipients</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Manner of submission; contents</h4>
<p class="statutory-body">A grant or contract under this part may be made upon application submitted to the Secretary at such time, in such manner, and containing and accompanied by such information, as the Secretary may require, including assurances for an evaluation whether performed by the applicant or by the Secretary. Such grant or <!-- PDFPage:813 -->contract may be made available on less than a statewide or regional basis. Each applicant shall&mdash;</p>
<p class="statutory-body-1em">(1) provide that the programs and activities for which assistance under this part is sought will be administered by or under the supervision of the applicant;</p>
<p class="statutory-body-1em">(2) provide for strict confidentiality of all test results, medical records, and other information regarding testing, diagnosis, counseling, or treatment of any person treated, except for (A) such information as the patient (or his guardian) gives informed consent to be released, or (B) statistical data compiled without reference to the identity of any such patient;</p>
<p class="statutory-body-1em">(3) provide for community representation where appropriate in the development and operation of voluntary genetic testing or counseling programs funded by a grant or contract under this part; and</p>
<p class="statutory-body-1em">(4) establish fiscal control and fund accounting procedures as may be necessary to assure proper disbursement of and accounting of Federal funds paid to the applicant under this part.</p>
<h4 class="subsection-head">(b) Considerations for grants and contracts under section 300b&ndash;1 of this title</h4>
<p class="statutory-body">In making grants and entering into contracts for any fiscal year under section 241 of this title for projects described in section 300b&ndash;1 of this title the Secretary shall give special consideration to applications from entities that received grants from, or entered into contracts with, the Secretary for the preceding fiscal year for the conduct of comprehensive sickle cell centers or sickle cell screening and education clinics.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1104, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 408; amended Pub. L. 95&ndash;626, title II, &sect;205(c), Nov. 10, 1978, 92 Stat. 3584; Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(2), (3), Aug. 13, 1981, 95 Stat. 827.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;3, act July 1, 1944, ch. 373, title XI, &sect;1104, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 138; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(3), 86 Stat. 652, authorized grants to be made upon application to Secretary and required supervision of programs by applicant, confidentiality of test results, medical records and other information obtained from treated person, community representation in programs, assurances by applicant that priority will be given to persons of child bearing years, and demonstration by applicant of proper fiscal control and accounting procedures, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1981&mdash;Subsec. (a)(4), (5). Pub. L. 97&ndash;35, &sect;2193(b)(2), redesignated par. (5) as (4). Former par. (4), which related to testing and counseling requirements, was struck out.</p>
<p class="note-body">Subsec. (b). Pub. L. 97&ndash;35, &sect;2193(b)(3), struck out subsec. (b) which related to grants and contracts under section 300b of this title. Former subsec. (c) was redesignated (b) and, as so redesignated, struck out reference to section 300b of this title.</p>
<p class="note-body">Subsec. (c). Pub. L. 97&ndash;35, &sect;2193(b)(3), redesignated subsec. (c) as (b).</p>
<p class="note-body">Subsec. (d). Pub. L. 97&ndash;35, &sect;2193(b)(3), struck out subsec. (d) which related to procedures applicable to grants, etc., under section 300b of this title.</p>
<p class="note-body">1978&mdash;Subsec. (a). Pub. L. 95&ndash;626, &sect;205(c)(1), inserted requirement that application contain assurances for an evaluation whether performed by applicant or by Secretary and that grant or contract be made available on less than a statewide or regional basis.</p>
<p class="note-body">Subsec. (d). Pub. L. 95&ndash;626, &sect;205(c)(2), added subsec. (d).</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1981 Amendment, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to amendment by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-4  usckey:420000000030000000000000b00040000 currentthrough:20100201 documentPDFPage:813 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-4 -->
<!-- itemsortkey:420ABLY -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-4 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;4. Public Health Service facilities</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">The Secretary shall establish a program within the Service to provide voluntary testing, diagnosis, counseling, and treatment of individuals respecting genetic diseases. Services under such program shall be made available through facilities of the Service to persons requesting such services, and the program shall provide appropriate publicity of the availability and voluntary nature of such services.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1105, as added Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 409.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 300b&ndash;4, act July 1, 1944, ch. 373, title XI, &sect;1105, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 139, authorized Secretary to establish a program within the Public Health Service with respect to sickle cell anemia with such program to be made available through facilities of Public Health Service, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-5  usckey:420000000030000000000000b00050000 currentthrough:20100201 documentPDFPage:813 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-5 -->
<!-- itemsortkey:420ABLZ -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-5 -->
<!-- field-start:repealedhead -->
<h3 class="section-head">&sect;300b&ndash;5. Repealed. Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(4), Aug. 13, 1981, 95 Stat. 827</h3>
<!-- field-end:repealedhead -->
<!-- field-start:repealsummary -->
<p class="note-body">Section, act July 1, 1944, ch. 373, title XI, &sect;1106, as added Apr. 22, 1976, Pub. L. 94&ndash;278, title IV, &sect;403(a), 90 Stat. 409, related to an annual report to President and Congress on administration of this part.</p>
<p class="note-body">A prior section 300b&ndash;5, act July 1, 1944, ch. 373, title XI, &sect;1106, as added May 16, 1972, Pub. L. 92&ndash;294, &sect;3(c), 86 Stat. 139; amended Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;4(3), 86 Stat. 652, related to an annual report to President and Congress on administration of this part, prior to repeal by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<!-- field-end:repealsummary -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-repeal-note -->
<h4 class="note-head">Effective Date of Repeal, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to repeal by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-repeal-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-6  usckey:420000000030000000000000b00060000 currentthrough:20100201 documentPDFPage:813 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-6 -->
<!-- itemsortkey:420ABMA -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-6 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;6. Applied technology</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">The Secretary, acting through an identifiable administrative unit, shall&mdash;</p>
<p class="statutory-body-1em">(1) conduct epidemiological assessments and surveillance of genetic diseases to define the scope and extent of such diseases and the need for programs for the diagnosis, treatment, and control of such diseases, screening for such diseases, and the counseling of persons with such diseases;</p>
<p class="statutory-body-1em">(2) on the basis of the assessments and surveillance described in paragraph (1), develop for use by the States programs which combine <!-- PDFPage:814 -->in an effective manner diagnosis, treatment, and control of such diseases, screening for such diseases, and counseling of persons with such diseases; and</p>
<p class="statutory-body-1em">(3) on the basis of the assessments and surveillance described in paragraph (1), provide technical assistance to States to implement the programs developed under paragraph (2) and train appropriate personnel for such programs.</p>
<br class="Q04" />
<p class="statutory-body-block">In carrying out this section, the Secretary may, from funds allotted for use under section 702(a) of this title, make grants to or contracts with public or nonprofit private entities (including grants and contracts for demonstration projects).</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1107, as added Pub. L. 95&ndash;626, title II, &sect;205(d)(1), Nov. 10, 1978, 92 Stat. 3584; amended Pub. L. 97&ndash;35, title XXI, &sect;2193(b)(5), Aug. 13, 1981, 95 Stat. 827.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1981&mdash;Pub. L. 97&ndash;35 substituted provisions relating to allotments under section 702(a) of this title for provisions relating to appropriations under section 300b(b) of this title.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1981 Amendment, Savings, and Transitional Provisions</h4>
<p class="note-body">For effective date, savings, and transitional provisions relating to amendment by Pub. L. 97&ndash;35, see section 2194 of Pub. L. 97&ndash;35, set out as a note under section 701 of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-7  usckey:420000000030000000000000b00070000 currentthrough:20100201 documentPDFPage:814 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-7 -->
<!-- itemsortkey:420ABMB -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-7 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;7. Tourette Syndrome</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary shall develop and implement outreach programs to educate the public, health care providers, educators and community based organizations about the etiology, symptoms, diagnosis and treatment of Tourette Syndrome, with a particular emphasis on children with Tourette Syndrome. Such programs may be carried out by the Secretary directly and through awards of grants or contracts to public or nonprofit private entities.</p>
<h4 class="subsection-head">(b) Certain activities</h4>
<p class="statutory-body">Activities under subsection (a) of this section shall include&mdash;</p>
<p class="statutory-body-1em">(1) the production and translation of educational materials, including public service announcements;</p>
<p class="statutory-body-1em">(2) the development of training material for health care providers, educators and community based organizations; and</p>
<p class="statutory-body-1em">(3) outreach efforts directed at the misdiagnosis and underdiagnosis of Tourette Syndrome in children and in minority groups.</p>
<h4 class="subsection-head">(c) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1108, as added Pub. L. 106&ndash;310, div. A, title XXIII, &sect;2301, Oct. 17, 2000, 114 Stat. 1157.)</p>
<!-- field-end:sourcecredit -->

<!-- documentid:42_300b-8  usckey:420000000030000000000000b00080000 currentthrough:20100201 documentPDFPage:814 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-8 -->
<!-- itemsortkey:420ABMC -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-8 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;8. Improved newborn and child screening for heritable disorders</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Authorization of grant program</h4>
<p class="statutory-body">From amounts appropriated under subsection (j), the Secretary, acting through the Administrator of the Health Resources and Services Administration (referred to in this section as the &ldquo;Administrator&rdquo;) and in consultation with the Advisory Committee on Heritable Disorders in Newborns and Children (referred to in this section as the &ldquo;Advisory Committee&rdquo;), shall award grants to eligible entities to enable such entities&mdash;</p>
<p class="statutory-body-1em">(1) to enhance, improve or expand the ability of State and local public health agencies to provide screening, counseling, or health care services to newborns and children having or at risk for heritable disorders;</p>
<p class="statutory-body-1em">(2) to assist in providing health care professionals and newborn screening laboratory personnel with education in newborn screening and training in relevant and new technologies in newborn screening and congenital, genetic, and metabolic disorders;</p>
<p class="statutory-body-1em">(3) to develop and deliver educational programs (at appropriate literacy levels) about newborn screening counseling, testing, follow-up, treatment, and specialty services to parents, families, and patient advocacy and support groups; and</p>
<p class="statutory-body-1em">(4) to establish, maintain, and operate a system to assess and coordinate treatment relating to congenital, genetic, and metabolic disorders.</p>
<h4 class="subsection-head">(b) Eligible entity</h4>
<p class="statutory-body">In this section, the term &ldquo;eligible entity&rdquo; means&mdash;</p>
<p class="statutory-body-1em">(1) a State or a political subdivision of a State;</p>
<p class="statutory-body-1em">(2) a consortium of 2 or more States or political subdivisions of States;</p>
<p class="statutory-body-1em">(3) a territory;</p>
<p class="statutory-body-1em">(4) a health facility or program operated by or pursuant to a contract with or grant from the Indian Health Service; or</p>
<p class="statutory-body-1em">(5) any other entity with appropriate expertise in newborn screening, as determined by the Secretary.</p>
<h4 class="subsection-head">(c) Approval factors</h4>
<p class="statutory-body">An application submitted for a grant under subsection (a)(1) shall not be approved by the Secretary unless the application contains assurances that the eligible entity has adopted and implemented, is in the process of adopting and implementing, or will use amounts received under such grant to adopt and implement the guidelines and recommendations of the Advisory Committee that are adopted by the Secretary and in effect at the time the grant is awarded or renewed under this section, which shall include the screening of each newborn for the heritable disorders recommended by the Advisory Committee and adopted by the Secretary.</p>
<h4 class="subsection-head">(d) Coordination</h4>
<p class="statutory-body">The Secretary shall take all necessary steps to coordinate programs funded with grants received under this section and to coordinate with existing newborn screening activities.</p>
<!-- PDFPage:815 --><h4 class="subsection-head">(e) Limitation</h4>
<p class="statutory-body">An eligible entity may not use amounts received under this section to&mdash;</p>
<p class="statutory-body-1em">(1) provide cash payments to or on behalf of affected individuals;</p>
<p class="statutory-body-1em">(2) provide inpatient services;</p>
<p class="statutory-body-1em">(3) purchase land or make capital improvements to property; or</p>
<p class="statutory-body-1em">(4) provide for proprietary research or training.</p>
<h4 class="subsection-head">(f) Voluntary participation</h4>
<p class="statutory-body">The participation by any individual in any program or portion thereof established or operated with funds received under this section shall be wholly voluntary and shall not be a prerequisite to eligibility for or receipt of any other service or assistance from, or to participation in, another Federal or State program.</p>
<h4 class="subsection-head">(g) Supplement not supplant</h4>
<p class="statutory-body">Funds appropriated under this section shall be used to supplement and not supplant other Federal, State, and local public funds provided for activities of the type described in this section.</p>
<h4 class="subsection-head">(h) Publication</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">An application submitted under subsection (c)(2)&nbsp;<sup><a href="#300b-8_1_target" name="300b-8_1">1</a></sup> of this section shall be made public by the State in such a manner as to facilitate comment from any person, including through hearings and other methods used to facilitate comments from the public.</p>
<h4 class="paragraph-head">(2) Comments</h4>
<p class="statutory-body-1em">Comments received by the State after the publication described in paragraph (1) shall be addressed in the application submitted under subsection (c)(2)&nbsp;<sup><a href="#300b-8_1_target" name="300b-8_1">1</a></sup> of this section.</p>
<h4 class="subsection-head">(i) Technical assistance</h4>
<p class="statutory-body">The Secretary shall provide to entities receiving grants under subsection (a) of this section such technical assistance as may be necessary to ensure the quality of programs conducted under this section.</p>
<h4 class="subsection-head">(j) Authorization of appropriations</h4>
<p class="statutory-body">There are authorized to be appropriated&mdash;</p>
<p class="statutory-body-1em">(1) to provide grants for the purpose of carrying out activities under subsection (a)(1), $15,000,000 for fiscal year 2009;&nbsp;<sup><a href="#300b-8_2_target" name="300b-8_2">2</a></sup> $15,187,500 for fiscal year 2010, $15,375,000 for fiscal year 2011, $15,562,500 for fiscal year 2012, and $15,750,000 for fiscal year 2013; and</p>
<p class="statutory-body-1em">(2) to provide grants for the purpose of carrying out activities under paragraphs (2), (3), and (4) of subsection (a), $15,000,000 for fiscal year 2009, $15,187,500 for fiscal year 2010, $15,375,000 for fiscal year 2011, $15,562,500 for fiscal year 2012, and $15,750,000 for fiscal year 2013.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1109, as added Pub. L. 106&ndash;310, div. A, title XXVI, &sect;2601, Oct. 17, 2000, 114 Stat. 1164; amended Pub. L. 110&ndash;204, &sect;2, Apr. 24, 2008, 122 Stat. 705; Pub. L. 110&ndash;237, &sect;1(a)(1), May 27, 2008, 122 Stat. 1556.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">Subsection (c)(2) of this section, referred to in subsec. (h)(1), (2), was struck out and a new subsec. (c) added by Pub. L. 110&ndash;204, &sect;2(1), Apr. 24, 2008, 122 Stat. 705.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsecs. (a) to (c). Pub. L. 110&ndash;204, &sect;2(1), added subsecs. (a) to (c) and struck out former subsecs. (a) to (c) which provided for grants to promote screening, counseling, or health care services to newborns and children having or at risk for heritable disorders, enumerated permissible uses of grants, and set out grant applicants&rsquo; eligibility requirements.</p>
<p class="note-body">Subsecs. (d) to (i). Pub. L. 110&ndash;204, &sect;2(2), (3), added subsec. (d) and redesignated former subsecs. (d) to (h) as (e) to (i), respectively. Former subsec. (i) redesignated (j).</p>
<p class="note-body">Subsec. (j). Pub. L. 110&ndash;237 added subsec. (j) and struck out former subsec. (j). Prior to amendment, text read as follows: &ldquo;There is authorized to be appropriated&mdash;</p>
<p class="note-body-1em">&ldquo;(1) to provide grants for the purpose of carrying activities under section (a)(1), $15,000,000 for fiscal year 2008; $15,187,500 for fiscal year 2009, $15,375,000 for fiscal year 2010, $15,562,500 for fiscal year 2011, and $15,750,000 for fiscal year 2012; and</p>
<p class="note-body-1em">&ldquo;(2) to provide grant for the purpose of carrying out activities under paragraphs (2), (3), and (4) of subsection (a), $15,000,000 for fiscal year 2008, $15,187,500 for fiscal year 2009, $15,375,000 for fiscal year 2010, $15,562,500 for fiscal year 2011, and $15,750,000 for fiscal year 2012.&rdquo;</p>
<p class="note-body">Pub. L. 110&ndash;204, &sect;2(4), added subsec. (j) and struck out former subsec. (j). Prior to amendment, text read as follows: &ldquo;There are authorized to be appropriated to carry out this section such sums as may be necessary for each of the fiscal years 2001 through 2005.&rdquo;</p>
<p class="note-body">Pub. L. 110&ndash;204, &sect;2(2), redesignated subsec. (i) as (j).</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->
<!-- field-start:footnote -->
<p class="footnote"><a href="#300b-8_1" name="300b-8_1_target"><sup>1</sup>&nbsp;See References in Text note below.</a></p>
<!-- field-end:footnote -->
<!-- field-start:footnote -->
<p class="footnote"><a href="#300b-8_2" name="300b-8_2_target"><sup>2</sup>&nbsp;So in original. The semicolon probably should be a comma.</a></p>
<!-- field-end:footnote -->

<!-- documentid:42_300b-9  usckey:420000000030000000000000b00090000 currentthrough:20100201 documentPDFPage:815 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-9 -->
<!-- itemsortkey:420ABMD -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-9 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;9. Evaluating the effectiveness of newborn and child screening programs</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary shall award grants to eligible entities to provide for the conduct of demonstration programs to evaluate the effectiveness of screening, counseling or health care services in reducing the morbidity and mortality caused by heritable disorders in newborns and children.</p>
<h4 class="subsection-head">(b) Demonstration programs</h4>
<p class="statutory-body">A demonstration program conducted under a grant under this section shall be designed to evaluate and assess, within the jurisdiction of the entity receiving such grant&mdash;</p>
<p class="statutory-body-1em">(1) the effectiveness of screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders in reducing the morbidity and mortality associated with such disorders;</p>
<p class="statutory-body-1em">(2) the effectiveness of screening, counseling, testing or specialty services in accurately and reliably diagnosing heritable disorders in newborns and children; or</p>
<p class="statutory-body-1em">(3) the availability of screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders.</p>
<h4 class="subsection-head">(c) Eligible entities</h4>
<p class="statutory-body">To be eligible to receive a grant under subsection (a) of this section an entity shall be a State or political subdivision of a State, or a consortium of two or more States or political subdivisions of States.</p>
<h4 class="subsection-head">(d) Authorization of appropriations</h4>
<p class="statutory-body">There are authorized to be appropriated to carry out this section $5,000,000 for fiscal year <!-- PDFPage:816 -->2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1110, as added Pub. L. 106&ndash;310, div. A, title XXVI, &sect;2601, Oct. 17, 2000, 114 Stat. 1165; amended Pub. L. 110&ndash;204, &sect;3, Apr. 24, 2008, 122 Stat. 706; Pub. L. 110&ndash;237, &sect;1(a)(2), May 27, 2008, 122 Stat. 1556.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsec. (d). Pub. L. 110&ndash;237 substituted &ldquo;2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.&rdquo; for &ldquo;2008, $5,062,500 for fiscal year 2009, $5,125,000 for fiscal year 2010, $5,187,500 for fiscal year 2011, and $5,250,000 for fiscal year 2012.&rdquo;</p>
<p class="note-body">Pub. L. 110&ndash;204 added subsec. (d).</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-10  usckey:420000000030000000000000b00100000 currentthrough:20100201 documentPDFPage:816 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-10 -->
<!-- itemsortkey:420ABME -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-10 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;10. Advisory Committee on Heritable Disorders in Newborns and Children</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment</h4>
<p class="statutory-body">The Secretary shall establish an advisory committee to be known as the &ldquo;Advisory Committee on Heritable Disorders in Newborns and Children&rdquo; (referred to in this section as the &ldquo;Advisory Committee&rdquo;).</p>
<h4 class="subsection-head">(b) Duties</h4>
<p class="statutory-body">The Advisory Committee shall&mdash;</p>
<p class="statutory-body-1em">(1) provide advice and recommendations to the Secretary concerning grants and projects awarded or funded under section 300b&ndash;8 of this title;</p>
<p class="statutory-body-1em">(2) provide technical information to the Secretary for the development of policies and priorities for the administration of grants under section 300b&ndash;8 of this title;</p>
<p class="statutory-body-1em">(3) make systematic evidence-based and peer-reviewed recommendations that include the heritable disorders that have the potential to significantly impact public health for which all newborns should be screened, including secondary conditions that may be identified as a result of the laboratory methods used for screening;</p>
<p class="statutory-body-1em">(4) develop a model decision-matrix for newborn screening expansion, including an evaluation of the potential public health impact of such expansion, and periodically update the recommended uniform screening panel, as appropriate, based on such decision-matrix;</p>
<p class="statutory-body-1em">(5) consider ways to ensure that all States attain the capacity to screen for the conditions described in paragraph (3), and include in such consideration the results of grant funding under section 300b&ndash;8 of this title; and</p>
<p class="statutory-body-1em">(6) provide such recommendations, advice or information as may be necessary to enhance, expand or improve the ability of the Secretary to reduce the mortality or morbidity from heritable disorders, which may include recommendations, advice, or information dealing with&mdash;</p>
<p class="statutory-body-2em">(A) follow-up activities, including those necessary to achieve rapid diagnosis in the short-term, and those that ascertain long-term case management outcomes and appropriate access to related services;</p>
<p class="statutory-body-2em">(B) implementation, monitoring, and evaluation of newborn screening activities, including diagnosis, screening, follow-up, and treatment activities;</p>
<p class="statutory-body-2em">(C) diagnostic and other technology used in screening;</p>
<p class="statutory-body-2em">(D) the availability and reporting of testing for conditions for which there is no existing treatment;</p>
<p class="statutory-body-2em">(E) conditions not included in the recommended uniform screening panel that are treatable with Food and Drug Administration-approved products or other safe and effective treatments, as determined by scientific evidence and peer review;</p>
<p class="statutory-body-2em">(F) minimum standards and related policies and procedures used by State newborn screening programs, such as language and terminology used by State newborn screening programs to include standardization of case definitions and names of disorders for which newborn screening tests are performed;</p>
<p class="statutory-body-2em">(G) quality assurance, oversight, and evaluation of State newborn screening programs, including ensuring that tests and technologies used by each State meet established standards for detecting and reporting positive screening results;</p>
<p class="statutory-body-2em">(H) public and provider awareness and education;</p>
<p class="statutory-body-2em">(I) the cost and effectiveness of newborn screening and medical evaluation systems and intervention programs conducted by State-based programs;</p>
<p class="statutory-body-2em">(J) identification of the causes of, public health impacts of, and risk factors for heritable disorders; and</p>
<p class="statutory-body-2em">(K) coordination of surveillance activities, including standardized data collection and reporting, harmonization of laboratory definitions for heritable disorders and testing results, and confirmatory testing and verification of positive results, in order to assess and enhance monitoring of newborn diseases.</p>
<h4 class="subsection-head">(c) Membership</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Secretary shall appoint not to exceed 15 members to the Advisory Committee. In appointing such members, the Secretary shall ensure that the total membership of the Advisory Committee is an odd number.</p>
<h4 class="paragraph-head">(2) Required members</h4>
<p class="statutory-body-1em">The Secretary shall appoint to the Advisory Committee under paragraph (1)&mdash;</p>
<p class="statutory-body-2em">(A) the Administrator of the Health Resources and Services Administration;</p>
<p class="statutory-body-2em">(B) the Director of the Centers for Disease Control and Prevention;</p>
<p class="statutory-body-2em">(C) the Director of the National Institutes of Health;</p>
<p class="statutory-body-2em">(D) the Director of the Agency for Healthcare Research and Quality;</p>
<p class="statutory-body-2em">(E) the Commissioner of the Food and Drug Administration;</p>
<p class="statutory-body-2em">(F) medical, technical, or scientific professionals with special expertise in heritable disorders, or in providing screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders;</p>
<p class="statutory-body-2em">(G) individuals with expertise in ethics and infectious diseases who have worked and <!-- PDFPage:817 -->published material in the area of newborn screening;</p>
<p class="statutory-body-2em">(H) members of the public having special expertise about or concern with heritable disorders; and</p>
<p class="statutory-body-2em">(I) representatives from such Federal agencies, public health constituencies, and medical professional societies as determined to be necessary by the Secretary, to fulfill the duties of the Advisory Committee, as established under subsection (b) of this section.</p>
<h4 class="subsection-head">(d) Decision on recommendations</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">Not later than 180 days after the Advisory Committee issues a recommendation pursuant to this section, the Secretary shall adopt or reject such recommendation.</p>
<h4 class="paragraph-head">(2) Pending recommendations</h4>
<p class="statutory-body-1em">The Secretary shall adopt or reject any recommendation issued by the Advisory Committee that is pending on April 24, 2008, by not later than 180 days after April 24, 2008.</p>
<h4 class="paragraph-head">(3) Determinations to be made public</h4>
<p class="statutory-body-1em">The Secretary shall publicize any determination on adopting or rejecting a recommendation of the Advisory Committee pursuant to this subsection, including the justification for the determination.</p>
<h4 class="subsection-head">(e) Annual report</h4>
<p class="statutory-body">Not later than 3 years after April 24, 2008, and each fiscal year thereafter, the Advisory Committee shall&mdash;</p>
<p class="statutory-body-1em">(1) publish a report on peer-reviewed newborn screening guidelines, including follow-up and treatment, in the United States;</p>
<p class="statutory-body-1em">(2) submit such report to the appropriate committees of Congress, the Secretary, the Interagency Coordinating Committee established under section 300b&ndash;13 of this title, and the State departments of health; and</p>
<p class="statutory-body-1em">(3) disseminate such report on as wide a basis as practicable, including through posting on the internet clearinghouse established under section 300b&ndash;11 of this title.</p>
<h4 class="subsection-head">(f) Continuation of operation of Committee</h4>
<p class="statutory-body">Notwithstanding section 14 of the Federal Advisory Committee Act (5 U.S.C. App.), the Advisory Committee shall continue to operate during the 5-year period beginning on April 24, 2008.</p>
<h4 class="subsection-head">(g) Authorization of appropriations</h4>
<p class="statutory-body">There are authorized to be appropriated to carry out this section, $1,000,000 for fiscal year 2009, $1,012,500 for fiscal year 2010, $1,025,000 for fiscal year 2011, $1,037,500 for fiscal year 2012, and $1,050,000 for fiscal year 2013.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1111, as added Pub. L. 106&ndash;310, div. A, title XXVI, &sect;2601, Oct. 17, 2000, 114 Stat. 1166; amended Pub. L. 110&ndash;204, &sect;4, Apr. 24, 2008, 122 Stat. 706; Pub. L. 110&ndash;237, &sect;1(a)(3), (b)(2), May 27, 2008, 122 Stat. 1556, 1557.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">Section 14 of the Federal Advisory Committee Act, referred to in subsec. (f), is section 14 of Pub. L. 92&ndash;463, which is set out in the Appendix to Title 5, Government Organization and Employees.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsec. (b)(3) to (5). Pub. L. 110&ndash;204, &sect;4(1)(B), (C), added pars. (3) to (5). Former par. (3) redesignated (6).</p>
<p class="note-body">Subsec. (b)(6). Pub. L. 110&ndash;204, &sect;4(1)(A), (D), redesignated par. (3) as (6), substituted &ldquo;,&nbsp;which may include recommendations, advice, or information dealing with&mdash;&rdquo; for period at end, and added subpars. (A) to (K).</p>
<p class="note-body">Subsec. (c)(2)(E) to (I). Pub. L. 110&ndash;204, &sect;4(2), as amended by Pub. L. 110&ndash;237, &sect;1(b)(2), added subpars. (E) and (G) and redesignated former subpars. (E), (F), and (G) as (F), (H), and (I), respectively.</p>
<p class="note-body">Subsec. (d). Pub. L. 110&ndash;204, &sect;4(3), added subsec. (d).</p>
<p class="note-body">Subsec. (d)(2). Pub. L. 110&ndash;237, &sect;1(a)(3)(A), made technical amendment to reference in original act which appears in text as the first reference to April 24, 2008.</p>
<p class="note-body">Subsecs. (e), (f). Pub. L. 110&ndash;237, &sect;1(a)(3)(B), (C), made technical amendment to references in original act which appear in text as references to April 24, 2008.</p>
<p class="note-body">Pub. L. 110&ndash;204, &sect;4(3), added subsecs. (e) and (f).</p>
<p class="note-body">Subsec. (g). Pub. L. 110&ndash;237, &sect;1(a)(3)(D), substituted &ldquo;2009, $1,012,500 for fiscal year 2010, $1,025,000 for fiscal year 2011, $1,037,500 for fiscal year 2012, and $1,050,000 for fiscal year 2013.&rdquo; for &ldquo;2008, $1,012,500 for fiscal year 2009, $1,025,000 for fiscal year 2010, $1,037,500 for fiscal year 2011, and $1,050,000 for fiscal year 2012.&rdquo;</p>
<p class="note-body">Pub. L. 110&ndash;204, &sect;4(3), added subsec. (g).</p>
<!-- field-end:amendment-note -->
<!-- field-start:terminationdate-note -->
<h4 class="note-head">Termination of Advisory Committees</h4>
<p class="note-body">Advisory committees established after Jan. 5, 1973, to terminate not later than the expiration of the 2-year period beginning on the date of their establishment, unless, in the case of a committee established by the President or an officer of the Federal Government, such committee is renewed by appropriate action prior to the expiration of such 2-year period, or in the case of a committee established by the Congress, its duration is otherwise provided by law. See section 14 of Pub. L. 92&ndash;463, Oct. 6, 1972, 86 Stat. 776, set out in the Appendix to Title 5, Government Organization and Employees.</p>
<p class="note-body">Pub. L. 93&ndash;641, &sect;6, Jan. 4, 1975, 88 Stat. 2275, set out as a note under section 217a of this title, provided that an advisory committee established pursuant to the Public Health Service Act shall terminate at such time as may be specifically prescribed by an Act of Congress enacted after Jan. 4, 1975.</p>
<!-- field-end:terminationdate-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-11  usckey:420000000030000000000000b00110000 currentthrough:20100201 documentPDFPage:817 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-11 -->
<!-- itemsortkey:420ABMF -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-11 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;11. Clearinghouse of newborn screening information</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary, acting through the Administrator of the Health Resources and Services Administration (referred to in this part as the &ldquo;Administrator&rdquo;), in consultation with the Director of the Centers for Disease Control and Prevention and the Director of the National Institutes of Health, shall establish and maintain a central clearinghouse of current educational and family support and services information, materials, resources, research, and data on newborn screening to&mdash;</p>
<p class="statutory-body-1em">(1) enable parents and family members of newborns, health professionals, industry representatives, and other members of the public to increase their awareness, knowledge, and understanding of newborn screening;</p>
<p class="statutory-body-1em">(2) increase awareness, knowledge, and understanding of newborn diseases and screening services for expectant individuals and families; and</p>
<p class="statutory-body-1em">(3) maintain current data on quality indicators to measure performance of newborn screening, such as false-positive rates and other quality indicators as determined by the Advisory Committee under section 300b&ndash;10 of this title.</p>
<h4 class="subsection-head">(b) Internet availability</h4>
<p class="statutory-body">The Secretary, acting through the Administrator, shall ensure that the clearinghouse described under subsection (a)&mdash;</p>
<!-- PDFPage:818 --><p class="statutory-body-1em">(1) is available on the Internet;</p>
<p class="statutory-body-1em">(2) includes an interactive forum;</p>
<p class="statutory-body-1em">(3) is updated on a regular basis, but not less than quarterly; and</p>
<p class="statutory-body-1em">(4) provides&mdash;</p>
<p class="statutory-body-2em">(A) links to Government-sponsored, non-profit, and other Internet websites of laboratories that have demonstrated expertise in newborn screening that supply research-based information on newborn screening tests currently available throughout the United States;</p>
<p class="statutory-body-2em">(B) information about newborn conditions and screening services available in each State from laboratories certified under subpart 2 of part F of subchapter II, including information about supplemental screening that is available but not required, in the State where the infant is born;</p>
<p class="statutory-body-2em">(C) current research on both treatable and not-yet treatable conditions for which newborn screening tests are available;</p>
<p class="statutory-body-2em">(D) the availability of Federal funding for newborn and child screening for heritable disorders including grants authorized under the Newborn Screening Saves Lives Act of 2008; and</p>
<p class="statutory-body-2em">(E) other relevant information as determined appropriate by the Secretary.</p>
<h4 class="subsection-head">(c) Nonduplication</h4>
<p class="statutory-body">In developing the clearinghouse under this section, the Secretary shall ensure that such clearinghouse minimizes duplication and supplements, not supplants, existing information sharing efforts.</p>
<h4 class="subsection-head">(d) Authorization of appropriations</h4>
<p class="statutory-body">There are authorized to be appropriated to carry out this section, $2,500,000 for fiscal year 2009, $2,531,250 for fiscal year 2010, $2,562,500 for fiscal year 2011, $2,593,750 for fiscal year 2012, and $2,625,000 for fiscal year 2013.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1112, as added Pub. L. 110&ndash;204, &sect;5, Apr. 24, 2008, 122 Stat. 708; amended Pub. L. 110&ndash;237, &sect;1(a)(4), May 27, 2008, 122 Stat. 1557.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The Newborn Screening Saves Lives Act of 2008, referred to in subsec. (b)(4)(D), is Pub. L. 110&ndash;204, Apr. 24, 2008, 122 Stat. 705, which enacted this section and sections 300b&ndash;12 to 300b&ndash;15 of this title, amended sections 300b&ndash;8 to 300b&ndash;10 of this title, and enacted provisions set out as a note under section 201 of this title. For complete classification of this Act to the Code, see Short Title of 2008 Amendment note set out under section 201 of this title and Tables.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsec. (b)(4)(D). Pub. L. 110&ndash;237, &sect;1(a)(4)(A), substituted &ldquo;2008&rdquo; for &ldquo;2007&rdquo;.</p>
<p class="note-body">Subsec. (d). Pub. L. 110&ndash;237, &sect;1(a)(4)(B), substituted &ldquo;2009, $2,531,250 for fiscal year 2010, $2,562,500 for fiscal year 2011, $2,593,750 for fiscal year 2012, and $2,625,000 for fiscal year 2013.&rdquo; for &ldquo;2008, $2,531,250 for fiscal year 2009, $2,562,500 for fiscal year 2010, $2,593,750 for fiscal year 2011, and $2,625,000 for fiscal year 2012.&rdquo;</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-12  usckey:420000000030000000000000b00120000 currentthrough:20100201 documentPDFPage:818 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-12 -->
<!-- itemsortkey:420ABMG -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-12 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;12. Laboratory quality</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in consultation with the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b&ndash;10 of this title, shall provide for&mdash;</p>
<p class="statutory-body-1em">(1) quality assurance for laboratories involved in screening newborns and children for heritable disorders, including quality assurance for newborn-screening tests, performance evaluation services, and technical assistance and technology transfer to newborn screening laboratories to ensure analytic validity and utility of screening tests; and</p>
<p class="statutory-body-1em">(2) appropriate quality control and other performance test materials to evaluate the performance of new screening tools.</p>
<h4 class="subsection-head">(b) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for fiscal year 2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1113, as added Pub. L. 110&ndash;204, &sect;6, Apr. 24, 2008, 122 Stat. 710; amended Pub. L. 110&ndash;237, &sect;1(a)(5), May 27, 2008, 122 Stat. 1557.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsec. (b). Pub. L. 110&ndash;237 substituted &ldquo;2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.&rdquo; for &ldquo;2008, $5,062,500 for fiscal year 2009, $5,125,000 for fiscal year 2010, $5,187,500 for fiscal year 2011, and $5,250,000 for fiscal year 2012.&rdquo;</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-13  usckey:420000000030000000000000b00130000 currentthrough:20100201 documentPDFPage:818 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-13 -->
<!-- itemsortkey:420ABMH -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-13 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;13. Interagency Coordinating Committee on Newborn and Child Screening</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Purpose</h4>
<p class="statutory-body">It is the purpose of this section to&mdash;</p>
<p class="statutory-body-1em">(1) assess existing activities and infrastructure, including activities on birth defects and developmental disabilities authorized under section 247b&ndash;4 of this title, in order to make recommendations for programs to collect, analyze, and make available data on the heritable disorders recommended by the Advisory Committee on Heritable Disorders in Newborns and Children under section 300b&ndash;10 of this title, including data on the incidence and prevalence of, as well as poor health outcomes resulting from, such disorders; and</p>
<p class="statutory-body-1em">(2) make recommendations for the establishment of regional centers for the conduct of applied epidemiological research on effective interventions to promote the prevention of poor health outcomes resulting from such disorders as well as providing information and education to the public on such effective interventions.</p>
<h4 class="subsection-head">(b) Establishment</h4>
<p class="statutory-body">The Secretary shall establish an Interagency Coordinating Committee on Newborn and Child Screening (referred to in this section as the &ldquo;Interagency Coordinating Committee&rdquo;) to carry out the purpose of this section.</p>
<h4 class="subsection-head">(c) Composition</h4>
<p class="statutory-body">The Interagency Coordinating Committee shall be composed of the Director of the Centers for Disease Control and Prevention, the Administrator, the Director of the Agency for Health<!-- PDFPage:819 -->care Research and Quality, and the Director of the National Institutes of Health, or their designees.</p>
<h4 class="subsection-head">(d) Activities</h4>
<p class="statutory-body">The Interagency Coordinating Committee shall&mdash;</p>
<p class="statutory-body-1em">(1) report to the Secretary and the appropriate committees of Congress on its recommendations related to the purpose described in subsection (a); and</p>
<p class="statutory-body-1em">(2) carry out other activities determined appropriate by the Secretary.</p>
<h4 class="subsection-head">(e) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated $1,000,000 for fiscal year 2009, $1,012,500 for fiscal year 2010, $1,025,000 for fiscal year 2011, $1,037,500 for fiscal year 2012, and $1,050,000 for fiscal year 2013.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1114, as added Pub. L. 110&ndash;204, &sect;6, Apr. 24, 2008, 122 Stat. 710; amended Pub. L. 110&ndash;237, &sect;1(a)(6), May 27, 2008, 122 Stat. 1557.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsec. (e). Pub. L. 110&ndash;237 substituted &ldquo;2009, $1,012,500 for fiscal year 2010, $1,025,000 for fiscal year 2011, $1,037,500 for fiscal year 2012, and $1,050,000 for fiscal year 2013.&rdquo; for &ldquo;2008, $1,012,500 for fiscal year 2009, $1,025,000 for fiscal year 2010, $1,037,500 for fiscal year 2011, and $1,050,000 for fiscal year 2012.&rdquo;</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:42_300b-14  usckey:420000000030000000000000b00140000 currentthrough:20100201 documentPDFPage:819 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-14 -->
<!-- itemsortkey:420ABMI -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-14 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;14. National contingency plan for newborn screening</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">Not later than 180 days after April 24, 2008, the Secretary, acting through the Director of the Centers for Disease Control and Prevention and in consultation with the Administrator and State departments of health (or related agencies), shall develop a national contingency plan for newborn screening for use by a State, region, or consortia&nbsp;<sup><a href="#300b-14_1_target" name="300b-14_1">1</a></sup> of States in the event of a public health emergency.</p>
<h4 class="subsection-head">(b) Contents</h4>
<p class="statutory-body">The contingency plan developed under subsection (a) shall include a plan for&mdash;</p>
<p class="statutory-body-1em">(1) the collection and transport of specimens;</p>
<p class="statutory-body-1em">(2) the shipment of specimens to State newborn screening laboratories;</p>
<p class="statutory-body-1em">(3) the processing of specimens;</p>
<p class="statutory-body-1em">(4) the reporting of screening results to physicians and families;</p>
<p class="statutory-body-1em">(5) the diagnostic confirmation of positive screening results;</p>
<p class="statutory-body-1em">(6) ensuring the availability of treatment and management resources;</p>
<p class="statutory-body-1em">(7) educating families about newborn screening; and</p>
<p class="statutory-body-1em">(8) carrying out other activities determined appropriate by the Secretary.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1115, as added Pub. L. 110&ndash;204, &sect;7, Apr. 24, 2008, 122 Stat. 711.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:footnote -->
<p class="footnote"><a href="#300b-14_1" name="300b-14_1_target"><sup>1</sup>&nbsp;So in original. Probably should be &ldquo;consortium&rdquo;.</a></p>
<!-- field-end:footnote -->

<!-- documentid:42_300b-15  usckey:420000000030000000000000b00150000 currentthrough:20100201 documentPDFPage:819 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER IX/Part A/Sec. 300b-15 -->
<!-- itemsortkey:420ABMJ -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER IX-GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME!@!Part A-Genetic Diseases!@!Sec. 300b-15 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;300b&ndash;15. Hunter Kelly Research Program</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Newborn screening activities</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Secretary, in conjunction with the Director of the National Institutes of Health and taking into consideration the recommendations of the Advisory Committee, may continue carrying out, coordinating, and expanding research in newborn screening (to be known as &ldquo;Hunter Kelly Newborn Screening Research Program&rdquo;) including&mdash;</p>
<p class="statutory-body-2em">(A) identifying, developing, and testing the most promising new screening technologies, in order to improve already existing screening tests, increase the specificity of newborn screening, and expand the number of conditions for which screening tests are available;</p>
<p class="statutory-body-2em">(B) experimental treatments and disease management strategies for additional newborn conditions, and other genetic, metabolic, hormonal, or functional conditions that can be detected through newborn screening for which treatment is not yet available; and</p>
<p class="statutory-body-2em">(C) other activities that would improve newborn screening, as identified by the Director.</p>
<h4 class="paragraph-head">(2) Additional newborn condition</h4>
<p class="statutory-body-1em">For purposes of this subsection, the term &ldquo;additional newborn condition&rdquo; means any condition that is not one of the core conditions recommended by the Advisory Committee and adopted by the Secretary.</p>
<h4 class="subsection-head">(b) Funding</h4>
<p class="statutory-body">In carrying out the research program under this section, the Secretary and the Director shall ensure that entities receiving funding through the program will provide assurances, as practicable, that such entities will work in consultation with the appropriate State departments of health, and, as practicable, focus their research on screening technology not currently performed in the States in which the entities are located, and the conditions on the uniform screening panel (or the standard test existing on the uniform screening panel).</p>
<h4 class="subsection-head">(c) Reports</h4>
<p class="statutory-body">The Director is encouraged to include information about the activities carried out under this section in the biennial report required under section 403 of the National Institutes of Health Reform Act of 2006.<sup><a href="#300b-15_1_target" name="300b-15_1">1</a></sup> If such information is included, the Director shall make such information available to be included on the Internet Clearinghouse established under section 300b&ndash;11 of this title.</p>
<h4 class="subsection-head">(d) Nonduplication</h4>
<p class="statutory-body">In carrying out programs under this section, the Secretary shall minimize duplication and supplement, not supplant, existing efforts of the type carried out under this section.</p>
<h4 class="subsection-head">(e) Peer review</h4>
<p class="statutory-body">Nothing in this section shall be construed to interfere with the scientific peer-review process at the National Institutes of Health.</p>
<!-- PDFPage:820 --><!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title XI, &sect;1116, as added Pub. L. 110&ndash;204, &sect;7, Apr. 24, 2008, 122 Stat. 711; amended Pub. L. 110&ndash;237, &sect;1(a)(7), May 27, 2008, 122 Stat. 1557.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">Section 403 of the National Institutes of Health Reform Act of 2006, referred to in subsec. (c), probably means section 403 of the Public Health Service Act, as added by section 104(a)(3) of the National Institutes of Health Reform Act of 2006, Pub. L. 109&ndash;482, which is classified to section 283 of this title.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">Prior sections 300c to 300c&ndash;4 were repealed by Pub. L. 94&ndash;278, title IV, &sect;403(a), Apr. 22, 1976, 90 Stat. 407.</p>
<p class="note-body">Section 300c, act July 1, 1944, ch. 373, title XI, &sect;1111, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 650, authorized Secretary to make grants and enter contracts with public and private entities for establishment of screening, treatment, and counseling programs with respect to Cooley's Anemia.</p>
<p class="note-body">Section 300c&ndash;1, act July 1, 1944, ch. 373, title XI, &sect;1112, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 651, required that any participation by an individual in any Cooley's Anemia programs should be on a purely voluntary basis.</p>
<p class="note-body">Section 300c&ndash;2, act July 1, 1944, ch. 373, title XI, &sect;1113, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 651, provided for making of grant upon application to Secretary and listed certain requirements to be met by applicant.</p>
<p class="note-body">Section 300c&ndash;3, act July 1, 1944, ch. 373, title XI, &sect;1114, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 652, authorized Secretary to establish a program with Public Health Service to provide for screening, counseling, and treatment with respect to Cooley's Anemia.</p>
<p class="note-body">Section 300c&ndash;4, act July 1, 1944, ch. 373, title XI, &sect;1115, as added Aug. 29, 1972, Pub. L. 92&ndash;414, &sect;3, 86 Stat. 652, provided for Secretary's submission of a report to President for transmittal to Congress annually.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2008&mdash;Subsec. (a)(1)(B). Pub. L. 110&ndash;237 substituted &ldquo;,&nbsp;or&rdquo; for &ldquo;and or&rdquo;.</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->


</body></html>